✦ LIBER ✦

303 Capecitabine plus oxaliplatin (XELOX): findings from a human colon cancer xenograft model and a phase II clinical trial in patients with metastatic colorectal cancer (MCRC)

✍ Scribed by N. Sawada; Y. Tanaka; C. Twelves; J. Tabernero; E. Diaz-Rubio; E. Van Cutsem

Book ID: 118620478
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 178 KB
Volume: 1
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(03)90336-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

636 POSTER Initial safety findings from

636 POSTER Initial safety findings from a phase III study of capecitabine (X) plus oxaliplatin (XELOX) vs. infusional 5-FU/LV plus oxaliplatin (FOLFOX-6) in first-line treatment of patients (pts) with metastatic colorectal cancer (MCRC)

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 258 KB

667 PUBLICATION Capecitabine and oxalipl

667 PUBLICATION Capecitabine and oxaliplatin (XELOX) in combination with bevacizumab in the treatment of metastatic colorectal cancer: results of a phase II trial

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 126 KB

O.9 Capecitabine (XELODA®, X) and oxalip

O.9 Capecitabine (XELODA®, X) and oxaliplatine (ELOXATIN®, LOHP) regimen (XELOX) in elderly patients with metastatic colorectal cancer (MCRC): a FNCLCC French Collaborative Group GERICO 02 phase II study

✍ Rousseau, F.; Bugat, R.; Ducreux, M.; Cvitkovic, F.; Carola, E.; Gisselbrecht, M 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 59 KB

3051 POSTER Phase II trial of sequential

3051 POSTER Phase II trial of sequential chemotherapy with capecitabine and irinotecan followed by capecitabine and oxaliplatin in elderly vulnerable patients (pts) with metastatic colorectal cancer (MCRC)

✍ S. Cupini; S. Bursi; G. Masi; F. Loupakis; C. Barbara; L. Fornaro; G. Allegrini; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Phase I/II trial of capecitabine and oxa

Phase I/II trial of capecitabine and oxaliplatin in combination with bevacizumab and imatinib in patients with metastatic colorectal cancer: AIO KRK 0205

✍ Hoehler, T; von Wichert, G; Schimanski, C; Kanzler, S; Moehler, M H; Hinke, A; S 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 202 KB

EPIC: Phase III Trial of Cetuximab Plus

EPIC: Phase III Trial of Cetuximab Plus Irinotecan After Fluoropyrimidine and Oxaliplatin Failure in Patients With Metastatic Colorectal Cancer

✍ Sobrero, A. F.; Maurel, J.; Fehrenbacher, L.; Scheithauer, W.; Abubakr, Y. A.; L 📂 Article 📅 2008 🏛 American Society of Clinical Oncology 🌐 English ⚖ 257 KB